Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

High-density lipoprotein levels have markedly increased over the past twenty years in Japan.

Yokoyama S, Ueshima H, Miida T, Nakamura M, Takata K, Fukukawa T, Goto T, Harada-Shiba M, Sano M, Kato K, Matsuda K.

J Atheroscler Thromb. 2014;21(2):151-60. Epub 2013 Oct 7.

PMID:
24096936
[PubMed - indexed for MEDLINE]
Free Article
2.

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.

van der Steeg WA, Holme I, Boekholdt SM, Larsen ML, Lindahl C, Stroes ES, Tikkanen MJ, Wareham NJ, Faergeman O, Olsson AG, Pedersen TR, Khaw KT, Kastelein JJ.

J Am Coll Cardiol. 2008 Feb 12;51(6):634-42. doi: 10.1016/j.jacc.2007.09.060.

PMID:
18261682
[PubMed - indexed for MEDLINE]
Free Article
3.

Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.

Boekholdt SM, Arsenault BJ, Hovingh GK, Mora S, Pedersen TR, Larosa JC, Welch KM, Amarenco P, Demicco DA, Tonkin AM, Sullivan DR, Kirby A, Colhoun HM, Hitman GA, Betteridge DJ, Durrington PN, Clearfield MB, Downs JR, Gotto AM Jr, Ridker PM, Kastelein JJ.

Circulation. 2013 Oct 1;128(14):1504-12. doi: 10.1161/CIRCULATIONAHA.113.002670. Epub 2013 Aug 21.

PMID:
23965489
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Optimal therapy of low levels of high density lipoprotein-cholesterol.

Kashyap ML, Tavintharan S, Kamanna VS.

Am J Cardiovasc Drugs. 2003;3(1):53-65. Review.

PMID:
14727946
[PubMed - indexed for MEDLINE]
5.

Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.

Mani P, Uno K, St John J, Tuzcu EM, Nissen SE, Nicholls SJ.

Am J Cardiol. 2014 Sep 1;114(5):681-5. doi: 10.1016/j.amjcard.2014.06.001. Epub 2014 Jun 18.

PMID:
25030535
[PubMed - indexed for MEDLINE]
6.

HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.

Tani S, Nagao K, Hirayama A.

Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.

PMID:
22149320
[PubMed - indexed for MEDLINE]
7.

Pitavastatin: clinical effects from the LIVES Study.

Teramoto T.

Atheroscler Suppl. 2011 Nov;12(3):285-8. doi: 10.1016/S1567-5688(11)70888-1. Review.

PMID:
22152283
[PubMed - indexed for MEDLINE]
8.

Effect of niacin on high-density lipoprotein apolipoprotein A-I kinetics in statin-treated patients with type 2 diabetes mellitus.

Pang J, Chan DC, Hamilton SJ, Tenneti VS, Watts GF, Barrett PH.

Arterioscler Thromb Vasc Biol. 2014 Feb;34(2):427-32. doi: 10.1161/ATVBAHA.113.302019. Epub 2013 Nov 27.

PMID:
24285582
[PubMed - indexed for MEDLINE]
9.
10.

Pitavastatin: novel effects on lipid parameters.

Chapman MJ.

Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X. Review.

PMID:
22152282
[PubMed - indexed for MEDLINE]
11.

Relationship of apolipoproteins A-1 and B, and lipoprotein(a) to cardiovascular outcomes: the AIM-HIGH trial (Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes).

Albers JJ, Slee A, O'Brien KD, Robinson JG, Kashyap ML, Kwiterovich PO Jr, Xu P, Marcovina SM.

J Am Coll Cardiol. 2013 Oct 22;62(17):1575-9. doi: 10.1016/j.jacc.2013.06.051. Epub 2013 Aug 21.

PMID:
23973688
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.

Kappelle PJ, Gansevoort RT, Hillege HJ, Wolffenbuttel BH, Dullaart RP; PREVEND Study Group.

J Clin Lipidol. 2013 Jan-Feb;7(1):56-64. doi: 10.1016/j.jacl.2012.05.003. Epub 2012 May 22.

PMID:
23351584
[PubMed - indexed for MEDLINE]
13.

Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.

Mora S, Buring JE, Ridker PM, Cui Y.

Ann Intern Med. 2011 Dec 6;155(11):742-50. doi: 10.7326/0003-4819-155-11-201112060-00006.

PMID:
22147713
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

High-density lipoproteins and cardiovascular disease: 2010 update.

Alwaili K, Awan Z, Alshahrani A, Genest J.

Expert Rev Cardiovasc Ther. 2010 Mar;8(3):413-23. doi: 10.1586/erc.10.4. Review.

PMID:
20222819
[PubMed - indexed for MEDLINE]
15.

Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study.

Hadaegh F, Harati H, Ghanbarian A, Azizi F.

Eur J Cardiovasc Prev Rehabil. 2006 Aug;13(4):571-7.

PMID:
16874147
[PubMed - indexed for MEDLINE]
16.

Prevalence and extent of dyslipidemia and recommended lipid levels in US adults with and without cardiovascular comorbidities: the National Health and Nutrition Examination Survey 2003-2004.

Ghandehari H, Kamal-Bahl S, Wong ND.

Am Heart J. 2008 Jul;156(1):112-9. doi: 10.1016/j.ahj.2008.03.005. Epub 2008 May 15.

PMID:
18585505
[PubMed - indexed for MEDLINE]
17.

Analysis of serum lipid levels in Japanese men and women according to body mass index. Increase in risk of atherosclerosis in postmenopausal women. Research Group on Serum Lipid Survey 1990 in Japan.

Yamamoto A, Horibe H, Mabuchi H, Kita T, Matsuzawa Y, Saito Y, Nakaya N, Fujioka T, Tenba H, Kawaguchi A, Nakamura H, Goto Y.

Atherosclerosis. 1999 Mar;143(1):55-73.

PMID:
10208480
[PubMed - indexed for MEDLINE]
18.

Are all statins the same? Focus on the efficacy and tolerability of pitavastatin.

da Silva PM.

Am J Cardiovasc Drugs. 2011;11(2):93-107. doi: 10.2165/11591190-000000000-00000. Review.

PMID:
21446776
[PubMed - indexed for MEDLINE]
19.

Low HDL cholesterol levels in type I Gaucher disease do not lead to an increased risk of cardiovascular disease.

de Fost M, Langeveld M, Franssen R, Hutten BA, Groener JE, de Groot E, Mannens MM, Bikker H, Aerts JM, Kastelein JJ, Hollak CE.

Atherosclerosis. 2009 May;204(1):267-72. doi: 10.1016/j.atherosclerosis.2008.08.027. Epub 2008 Sep 2.

PMID:
18842264
[PubMed - indexed for MEDLINE]
20.

A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.

Sasaki J, Ikeda Y, Kuribayashi T, Kajiwara K, Biro S, Yamamoto K, Ageta M, Kobori S, Saikawa T, Otonari T, Kono S.

Clin Ther. 2008 Jun;30(6):1089-101. doi: 10.1016/j.clinthera.2008.05.017.

PMID:
18640465
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk